Artesunate

Artesunate is an intravenous antimalarial medication used to treat severe Plasmodium falciparum malaria by killing parasites through oxidative stress. It is recognized by the WHO as first-line, with FDA approval for this indication granted in 2020. Common side effects include dizziness, nausea, vomiting, and headache, with rare risks of delayed hemolysis